TRGP Financial Statements & Analysis
Complete financial statements for TRGP including income statement, balance sheet, and cash flow statement. Analyze TRGP's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
60
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
6.5% ↑
Net Income
53.3% ↑
Gross Margin
23.2% ↑
Operating Margin
26.5% ↑
Balance Sheet
Current Ratio
-8.9% ↓
Debt to Equity
15.9% ↓
Asset Turnover
-3.2% ↓
Cash Flow
Operating Cash Flow
13.6% ↑
Net Cash Flow
120.2% ↑
Free Cash Flow
-17.2% ↓
Cash Flow to Debt
3.6% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 15.62B | 16.63B | 6.5% | |
| Gross Profit | 2.54B | 3.33B | 31.2% | |
| Operating Income | 2.19B | 2.94B | 34.6% | |
| Net Income | 828.20M | 1.27B | 53.3% | |
| EPS | 3.6874 | 5.7652 | 56.3% | |
| EBITDA | 3.97B | 4.14B | 4.4% | |
| Gross Margin | 16.23% | 20.00% | 23.2% | |
| Operating Margin | 14.00% | 17.71% | 26.5% | |
| Net Income Margin | 5.30% | 7.64% | 44.0% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 16.63B | 15.62B | 21.68B | 17.44B | 8.27B |
| Gross Profit | 3.33B | 2.54B | 2.79B | 2.09B | 1.52B |
| Operating Income | 2.94B | 2.19B | 2.48B | 1.82B | 1.27B |
| Net Income | 1.27B | 828.20M | 1.14B | 71.20M | -1553900000 |
| EPS | 5.7652 | 3.6874 | 3.9454 | -0.0704 | -7.2558 |
| EBITDA | 4.14B | 3.97B | 3.21B | 1.70B | -313100000 |
| Gross Margin | 20.00% | 16.23% | 12.88% | 12.00% | 18.40% |
| Operating Margin | 17.71% | 14.00% | 11.45% | 10.44% | 15.30% |
| Net Income Margin | 7.64% | 5.30% | 5.27% | 0.41% | -18.78% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |